A Phase III, Multi-centre, Randomized Study to Compare the Efficacy and Safety of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2018
At a glance
- Drugs Alalevonadifloxacin (Primary) ; Levonadifloxacin (Primary) ; Linezolid; Linezolid
- Indications Bacterial infections; Skin infections
- Focus Registrational; Therapeutic Use
- Sponsors Wockhardt
- 12 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 30 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 25 Sep 2018.
- 08 Jan 2018 Status changed from not yet recruiting to recruiting.